Innoviva director granted RSUs and stock options
Innoviva, Inc. director Sarah J. Schlesinger received new equity compensation awards.
Rhea-AI Filing Summary
Innoviva, Inc. director Sarah J. Schlesinger received new equity compensation awards. She was granted 9,786 shares of common stock in the form of restricted stock units and a non-statutory stock option for 10,000 shares at an exercise price of $22.99 per share.
These grants were made following Innoviva’s 2026 annual meeting of stockholders and are compensation awards, not open-market purchases. All of the RSUs and options vest 100% at the earlier of the next annual stockholder meeting or the one-year anniversary of the grant, contingent on her continued service as an Outside Director, with accelerated vesting upon death, disability, or a qualifying change in control under the 2026 Equity Incentive Plan.
After these awards, she directly holds 140,492 shares of common stock and 10,000 options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 19,786 shares
Grant/Award
2 txns
Insider
Schlesinger Sarah J.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-statutory Stock Option | 10,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 9,786 | $0.00 | $0.00 |
Holdings After Transaction:
Non-statutory Stock Option — 10,000 contracts (Direct);
Common Stock — 140,492 shares (Direct)
Footnotes (1)
- F1. The Reporting Person was granted restricted stock units ("RSUs") and non-statutory stock options ("Options") upon the conclusion of the Issuer's 2026 annual meeting of stockholders. 100% of the RSUs and Options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date, with accelerated vesting upon the Reporting Person's death, disability, or in the event of a "change in control" (as defined in the Issuer's 2026 Equity Incentive Plan), provided that the Reporting Person has not experienced a termination prior to such "change in control," death or disability.
Key Figures
RSU grant: 9,786 shares
Option grant size: 10,000 options
Option exercise price: $22.99/share
+2 more
5 metrics
RSU grant
9,786 shares
Restricted stock units granted to Outside Director at 2026 annual meeting
Option grant size
10,000 options
Non-statutory stock options on common stock
Option exercise price
$22.99/share
Conversion or exercise price for non-statutory stock option
Shares after award
140,492 shares
Total Innoviva common shares held directly after RSU grant
Option expiration
May 3, 2036
Expiration date of non-statutory stock options
Key Terms
restricted stock units ("RSUs"), non-statutory stock options, change in control, 2026 Equity Incentive Plan, +1 more
5 terms
restricted stock units ("RSUs") financial
"The Reporting Person was granted restricted stock units ("RSUs") and non-statutory stock options"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
non-statutory stock options financial
"restricted stock units ("RSUs") and non-statutory stock options ("Options") upon the conclusion"
Non-statutory stock options are a type of reward that companies give to employees, allowing them to buy company shares at a set price within a certain period. Unlike formal or government-approved plans, these options are more flexible but may have different tax implications. For investors, they can influence a company's stock price and financial health, making them an important factor to consider.
change in control financial
"in the event of a "change in control" (as defined in the Issuer's 2026 Equity Incentive Plan)"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
2026 Equity Incentive Plan financial
""change in control" (as defined in the Issuer's 2026 Equity Incentive Plan)"
Outside Director financial
"subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Innoviva (INVA) grant to director Sarah J. Schlesinger?
Innoviva granted Sarah J. Schlesinger 9,786 restricted stock units and a non-statutory stock option for 10,000 shares. The option has an exercise price of $22.99 per share and is part of her compensation as an Outside Director.
Are Sarah J. Schlesinger’s new Innoviva (INVA) awards open-market purchases?
No, the awards are compensation grants, not open-market purchases. She received restricted stock units and non-statutory stock options following Innoviva’s 2026 annual stockholder meeting as part of the company’s 2026 Equity Incentive Plan for Outside Directors.
When do Sarah J. Schlesinger’s Innoviva (INVA) RSUs and options vest?
All RSUs and options vest 100% at the earlier of the next annual stockholder meeting or the one-year anniversary of grant. Vesting requires continuous service as an Outside Director, with accelerated vesting upon death, disability, or a qualifying change in control.
What is the exercise price and term of Sarah J. Schlesinger’s Innoviva (INVA) options?
Her non-statutory stock options cover 10,000 shares of Innoviva common stock at an exercise price of $22.99 per share. These options are scheduled to expire on May 3, 2036, giving a long exercise window after vesting.
What triggers accelerated vesting of Sarah J. Schlesinger’s Innoviva (INVA) equity awards?
Accelerated vesting occurs upon her death, disability, or a “change in control” as defined in Innoviva’s 2026 Equity Incentive Plan. This acceleration applies if she has not experienced a termination before such change in control, death, or disability.
AI-generated analysis. How Rhea-AI works. Not financial advice.
